lapatinib has been researched along with gatifloxacin in 2 studies
Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (gatifloxacin) | Trials (gatifloxacin) | Recent Studies (post-2010) (gatifloxacin) |
---|---|---|---|---|---|
1,919 | 305 | 1,442 | 1,047 | 131 | 268 |
Protein | Taxonomy | lapatinib (IC50) | gatifloxacin (IC50) |
---|---|---|---|
DNA gyrase subunit A | Escherichia coli K-12 | 0.5 | |
DNA gyrase subunit B | Escherichia coli K-12 | 0.5 | |
DNA topoisomerase 4 subunit A | Staphylococcus aureus | 1.2 | |
DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | 9.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB | 1 |
2 other study(ies) available for lapatinib and gatifloxacin
Article | Year |
---|---|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Navigating the kinome.
Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology | 2011 |